8-KLeadership ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Executive Changes (Mar 10, 2022)

Filed March 10, 2022For Securities:CVS

Summary

CVS Health Corporation (CVS) filed an 8-K on March 10, 2022, to announce a significant change in its Board of Directors leadership. David W. Dorman, the current Chair of the Board, has indicated his intention to retire at the end of his current term and will not seek re-election at the upcoming Annual Meeting of Stockholders on May 11, 2022. This retirement is stated to be amicable and not due to any disagreements. In conjunction with Mr. Dorman's upcoming departure, the Board has appointed Roger N. Farah, an existing independent director, to become the new Chair of the Board, effective May 11, 2022, contingent upon his re-election. Additionally, independent director Tony L. White will also be retiring from the Board due to reaching the mandatory retirement age. These leadership transitions are formally announced via a press release filed as an exhibit to this 8-K.

Key Highlights

  • 1Current Board Chair David W. Dorman will retire and not stand for re-election at the May 11, 2022 Annual Meeting.
  • 2Mr. Dorman's retirement is not a result of any disagreements with the company.
  • 3Independent Director Tony L. White will also retire from the Board due to reaching mandatory retirement age.
  • 4Roger N. Farah, an existing independent director, has been selected to succeed Mr. Dorman as Chair of the Board.
  • 5Mr. Farah's appointment as Chair is effective May 11, 2022, subject to his re-election.
  • 6The company issued a press release on March 10, 2022, detailing these leadership changes.

Frequently Asked Questions

David W. Dorman intends to retire at the end of his current term and will not stand for re-election. The company states that his retirement is not due to any disagreements with CVS Health.

Roger N. Farah, an independent director who has served on the Board since November 2018, has been selected to become the new Chair of the Board.

The leadership changes, including the retirement of Mr. Dorman and Mr. White and the appointment of Mr. Farah as Chair, are effective upon the Annual Meeting of Stockholders on May 11, 2022. Mr. Farah's appointment is also subject to his re-election at that meeting.

Yes, Tony L. White, an independent director, will also be retiring from the Board at the Annual Meeting of Stockholders due to reaching the mandatory retirement age.